Document Detail


Sulfhydryl reagents as model substances for eicosanoid research.
MedLine Citation:
PMID:  3272823     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The rate of eicosanoid synthesis is controlled by the availability of free arachidonic acid. Recently we showed that inhibition of reacylation of liberated fatty acids by the sulfhydryl group-blocking agent thimerosal increased prostaglandin as well as leukotriene synthesis. In order to gain further insight into the basic regulatory mechanisms controlling cellular eicosanoid production, the effects of different sulfhydryl reagents on prostaglandin E2 synthesis in the macrophage-like cell line P388D1 were investigated. As these cells exhibit an enormous acyl turnover of cellular phospholipids even under basal conditions, any interference with their fatty acid deacylation-reacylation cycle should lead to a change in intracellular concentrations of the eicosanoid precursor arachidonic acid. Therefore, arachidonic acid release from prelabelled cells as well as arachidonic acid incorporation into different phospholipid species under the influence of mercuric chloride (HgCl2), ethylmercurithiosalicylate (thimerosal), p-hydroxymercuribenzoic acid (PHMB), 0-(3-hydroxymercuri-3-methoxypropyl)carbamoyl-phenoxyacetic acid (mersalyl), N-ethylmaleimide (NEM), and ethacrynic acid were examined. Additionally, direct effects of those substances on corresponding enzyme activities, i.e. phospholipase A2 (PLA2), acyl-CoA synthetase, and lysophospholipid acyltransferase (LAT), on glutathione levels, and on cell viability were estimated. The results demonstrate that the organic mercury compound thimerosal was the most effective in enhancing free arachidonic acid levels, and concomitantly prostaglandin E2 synthesis in P388D1 cells, as result of a rather selective inhibition of the fatty acid reacylating enzyme LAT.
Authors:
V Kaever; U Firla; K Resch
Related Documents :
2816873 - Prostaglandins e2 and e2 alpha are elevated in saliva of cystic fibrosis patients.
3286393 - Ritodrine infusion at term: effects on maternal and fetal prostacyclin, thromboxane and...
15618643 - The 9cis,11trans,13cis isomer of conjugated linolenic acid reduces apolipoprotein b100 ...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Eicosanoids     Volume:  1     ISSN:  0934-9820     ISO Abbreviation:  Eicosanoids     Publication Date:  1988  
Date Detail:
Created Date:  1990-04-26     Completed Date:  1990-04-26     Revised Date:  2008-11-21    
Medline Journal Info:
Nlm Unique ID:  8906009     Medline TA:  Eicosanoids     Country:  GERMANY, EAST    
Other Details:
Languages:  eng     Pagination:  49-57     Citation Subset:  IM    
Affiliation:
Department of Pharmacology and Toxicology, Medical School Hannover, Federal Republic of Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acyltransferases / metabolism
Arachidonic Acids / metabolism*
Cell Line
Cell Survival / drug effects
Chemical Phenomena
Chemistry
Coenzyme A Ligases / metabolism
Dinoprostone / biosynthesis
Dose-Response Relationship, Drug
Eicosanoids / biosynthesis*
Glutathione
Phospholipases A / metabolism
Phospholipases A2
Phospholipids / analysis
Sulfhydryl Reagents / diagnostic use*
Chemical
Reg. No./Substance:
0/Arachidonic Acids; 0/Eicosanoids; 0/Phospholipids; 0/Sulfhydryl Reagents; 363-24-6/Dinoprostone; 70-18-8/Glutathione; EC 2.3.-/Acyltransferases; EC 3.1.1.-/Phospholipases A; EC 3.1.1.4/Phospholipases A2; EC 6.2.1.-/Coenzyme A Ligases

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  12(S)-Hydroxy-5,8,10 (Z,E,E)-heptadecatrienoic acid (HHT) is preferentially metabolized to its 12-ke...
Next Document:  Inhibition of hydrogen peroxide release from activated macrophages by prior ingestion of erythrocyte...